Jodie L Babitt

This inventor holds 11 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: The General Hospital Corporation, Ferrumax Corporation. Active years: 2011-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jodie L Babitt. Retrieved from https://idiyas.com/inventor/jodie-l-babitt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 36.4

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 170(Granted Patents)

Location History:

Newton Highlands, MA (US) (2012 - 2019)
Newton, MA (US) (2011 - 2020)

Company Filing History:

11 out of 3,073

The General Hospital Corporation

where one patent can have more than one assignee

Years Active: 2011-2020

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10611820 - Nucleic acids encoding hemojuvelin fusion proteins and uses thereof (2020-04-07),

2. 10273273 - Compositions for regulating iron homeostasis and methods of using same (2019-04-30),

3. 9758567 - Hemojuvelin fusion proteins and uses thereof (2017-09-12),

4. 9708379 - Compositions for regulating iron homeostasis and methods of using same (2017-07-18),

5. 9556251 - Methods and compositions to regulate hepcidin expression (2017-01-31),

6. 8895002 - Hemojuvelin fusion proteins and uses thereof (2014-11-25),

7. 8865168 - Methods and compositions to regulate hepcidin expression (2014-10-21),

8. 8637023 - Hemojuvelin fusion proteins (2014-01-28),

9. 8318167 - Methods and compositions for regulating iron homeostasis by modulation of BMP-6 (2012-11-27),

10. 8293236 - Use of modulators of compounds of TGF-β superfamily to regulate hepcidin-mediated iron metabolism (2012-10-23),

11. 7968091 - Methods and compositions to regulate iron metabolism (2011-06-28),

Title: Innovations and Contributions of Jodie L Babitt

Introduction

Jodie L Babitt is a prominent inventor based in Newton Highlands, MA (US). She has made significant contributions to the field of medical science, particularly in the area of iron homeostasis. With a total of 11 patents to her name, her work has had a profound impact on the treatment of iron-related disorders.

Latest Patents

Among her latest patents is the invention titled "Nucleic acids encoding hemojuvelin fusion proteins and uses thereof." This invention provides a hemojuvelin (HJV) fusion protein, such as a human HJV.Fc protein, along with polynucleotides and vectors encoding these proteins. The methods outlined in this patent focus on treating iron-related disorders through the administration of HJV fusion proteins to patients in need. Another notable patent is "Compositions for regulating iron homeostasis and methods of using same." This invention relates to hemojuvelin-IgG Fc domain fusion proteins and their derivatives, which are utilized for regulating iron homeostasis and treating diseases associated with iron imbalances.

Career Highlights

Jodie has worked with esteemed organizations, including The General Hospital Corporation and Ferrumax Corporation. Her experience in these institutions has allowed her to develop and refine her innovative ideas, contributing to advancements in medical treatments.

Collaborations

Throughout her career, Jodie has collaborated with notable colleagues, including Herbert Y Lin and Clifford J Woolf. These partnerships have fostered a collaborative environment that has enhanced her research and development efforts.

Conclusion

Jodie L Babitt's contributions to the field of medical science through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in the treatment of iron-related disorders.

Profile summary based on public USPTO records.